Pentadecanoic acid, written in shorthand as C15:0, is a 15-carbon saturated fatty acid that occurs naturally in full-fat dairy products and the fat of ruminant animals such as beef and lamb. Unlike the even-chain saturated fats that dominate most dietary discussions, C15:0 belongs to a less-studied class called odd-chain fatty acids, which the body handles somewhat differently at a metabolic level.
Interest in C15:0 has grown in recent years largely because of research from a group of scientists at the biotechnology company Epitracker, who have proposed that this fatty acid may support cellular health through several distinct mechanisms. Their hypothesis — that C15:0 might be considered an essential fatty acid for humans — remains preliminary and has not been formally adopted by regulatory bodies or mainstream nutrition organizations. What follows is an honest summary of what C15:0 is and what current science suggests, without overstating a field that is still in early stages.
Key Takeaways
- C15:0 is a 15-carbon saturated odd-chain fatty acid found primarily in full-fat dairy products and ruminant animal fat.
- Proposed mechanisms include cell membrane stabilization, partial PPAR-α/δ receptor agonism, and potential effects on ferroptosis and cellular senescence — all of which remain early-stage hypotheses.
- The classification of C15:0 as an ‘essential’ fatty acid is a hypothesis from Epitracker researchers; it has not been formally adopted by the FDA or mainstream nutrition science bodies.
- Supplemental C15:0 at 100–300 mg/day has been generally well-tolerated in published research, but long-term safety data and independent replication are still limited.
- This is a developing area of nutritional science worth monitoring, but current evidence does not support treating C15:0 as a proven remedy for any specific health condition.
The Chemistry of C15:0
Pentadecanoic acid is a straight-chain, fully saturated fatty acid with 15 carbon atoms. The ‘0’ in C15:0 indicates zero double bonds, meaning every carbon in its chain is fully bonded to hydrogen atoms. This distinguishes it from unsaturated fatty acids like oleic acid (C18:1) or omega-3s, which contain one or more double bonds that introduce kinks into their structure.
Odd-chain fatty acids like C15:0 are produced in small quantities by the forestomach bacteria of ruminants during fermentation of plant fiber. When ruminant animals such as cows, goats, or sheep consume grass and hay, their gut microbes synthesize these odd-chain fats, which then deposit into the animal’s milk fat and body fat. This is why full-fat dairy — butter, whole milk, aged cheese — is among the most consistent dietary sources of C15:0 for humans.
The body does not synthesize C15:0 in meaningful amounts on its own. Most human C15:0 comes from diet, though very small amounts can theoretically arise from the incomplete oxidation of even-chain fatty acids. This limited endogenous production is part of why some researchers argue it may warrant dietary consideration.
Where C15:0 Is Found in Food
The richest natural sources of C15:0 are full-fat dairy products. Butter, whole cow’s milk, cream, and aged hard cheeses contain the highest concentrations. The fatty acid profile of dairy varies depending on the animal’s breed, diet, and season: grass-fed ruminants generally produce milk with higher odd-chain fatty acid content than grain-fed counterparts.
Fatty fish — particularly certain marine species — also contain detectable amounts of C15:0, as do some fermented foods. However, dairy fat remains the most practical and well-studied dietary source for most people in Western countries. Individuals who avoid all animal products or follow strict low-fat diets will typically have lower circulating levels of C15:0, which is part of what motivated researchers to develop C15:0 supplements as an alternative delivery route.
It is worth noting that C15:0 is just one component of a complex fat matrix. Eating full-fat dairy for its C15:0 content also means consuming other saturated fats, calories, and nutrients. Whether the benefits proposed for isolated C15:0 supplementation apply equally to whole-food dairy consumption is not yet established.
Proposed Mechanisms: How C15:0 May Work in Cells
Researchers have proposed several mechanisms by which C15:0 might influence cellular health. The first is structural: like other fatty acids, C15:0 can incorporate into cell membranes, where its odd-chain length may confer a different kind of rigidity or fluidity compared to even-chain saturated fats. Epitracker scientists have suggested this membrane integration may help stabilize cells and reduce what they call ‘cellular fragility.’
A second proposed mechanism involves nuclear receptors. C15:0 is reported to act as a partial agonist of peroxisome proliferator-activated receptors alpha and delta (PPAR-α and PPAR-δ). These receptors regulate genes involved in fatty acid oxidation, mitochondrial function, and inflammation. Partial agonism — as opposed to full agonism — means the fatty acid may activate these receptors at a more moderate level than pharmaceutical PPAR agonists, which have historically carried safety concerns.
Two additional cellular-level hypotheses have been raised: that C15:0 may help reduce ferroptosis, a form of iron-dependent regulated cell death linked to lipid oxidation, and that it may reduce cellular senescence, the state in which cells stop dividing but remain metabolically active and can secrete pro-inflammatory signals. Both of these are areas of active general research in aging science, and C15:0’s role within them is speculative and early-stage.
The 'Essential Fatty Acid' Hypothesis
The claim most associated with C15:0 in popular media is that it is a newly discovered essential fatty acid — meaning the body cannot make enough of it on its own and must obtain adequate amounts from diet. This hypothesis originates primarily from Epitracker-affiliated researchers and has been published in peer-reviewed journals. However, the classification of C15:0 as ‘essential’ in the formal nutritional sense has not been adopted by the U.S. Food and Drug Administration, the European Food Safety Authority, or major nutrition bodies such as the National Academies of Sciences.
To be classified as essential, a nutrient typically needs a demonstrated deficiency syndrome in otherwise healthy individuals consuming a diet lacking it, along with consistent evidence that repletion resolves that syndrome. The research on C15:0 has not yet reached that evidentiary threshold. What the existing research does suggest is an association between higher circulating C15:0 levels and certain health markers — but association is not the same as established essentiality.
This nuance matters for consumers. The science is genuinely interesting and worth following. But describing C15:0 as proven essential overstates what the current body of evidence supports.
C15:0 Supplements: Doses and Tolerability
Supplemental C15:0 is sold primarily under the brand name Fatty15, developed by Epitracker. Published research on supplementation has generally used doses in the range of 100 to 300 milligrams per day. At these doses, no serious adverse events have been reported in published studies, and participants have generally tolerated the supplement well. No published clinical trials have tested higher doses, and long-term safety data beyond the timeframes studied is not yet available.
The FDA has not evaluated C15:0 supplements for any disease treatment or prevention. Like most dietary supplements sold in the United States, they are regulated under DSHEA (the Dietary Supplement Health and Education Act), which does not require pre-market safety or efficacy approval. This means the burden of evidence for therapeutic claims is much lower than for pharmaceutical drugs.
People with fish or dairy allergies, those on lipid-altering medications, those who are pregnant or breastfeeding, or those managing any chronic health condition should consult a physician before adding C15:0 supplements to their routine. The interaction profile of C15:0 with medications has not been systematically studied.
What the Research Does and Does Not Show
The existing published evidence on C15:0 includes epidemiological studies examining associations between circulating odd-chain fatty acid levels and health outcomes, cell culture studies examining how C15:0 affects membrane properties and receptor activity, and a small number of human supplementation trials. These studies are generally small in sample size and short in duration. Most originate from or are affiliated with Epitracker, which means independent replication — a cornerstone of scientific confidence — is limited.
Cell culture findings and rodent studies, which make up a significant portion of the mechanistic work, do not automatically translate to equivalent effects in humans. Many compounds show promising activity in isolated cells or animals and do not perform similarly in clinical trials. This is a standard limitation of early-stage nutritional science, not a specific criticism of C15:0 research.
The honest summary is this: C15:0 is a real, identifiable fatty acid with plausible biological mechanisms and preliminary supportive data. It is not a proven treatment for any disease, and the evidence base is not yet strong enough to draw firm clinical conclusions. Researchers and health-interested individuals alike should follow this space as larger, independent studies are conducted.
🛒 Where to Buy Pentadecanoic Acid (C15:0)
- Epitracker Fatty15 C15:0 Fatty Acid SupplementLab-tested / studied
capsules, 100 mg C15:0 per capsule; 1 capsule/day starter, 2 capsules/day maintenance — Category creator; the only C15:0 supplement backed by the original Epitracker research team (Venn-Watson et al.); uses a patented, sustainably-sourced pure C15:0 ingredient; most expensive per-capsule but reference product for all comparisons - Double Wood Supplements Pentadecanoic Acid C15:0
capsules, 200 mg C15:0 per serving (2 capsules) — One of the first genericized C15:0 supplements; significantly lower price than Fatty15; no independent clinical trials on this specific product; good option for budget-conscious buyers who want to trial the fatty acid - Sports Research Pentadecanoic Acid C15:0
softgels, 100 mg C15:0 per softgel — Established supplement brand with strong Amazon presence; third-party tested; softgel form may aid fat-soluble absorption; competitively priced mid-tier option - BulkSupplements Pentadecanoic Acid Powder (C15:0)
powder, 100–300 mg per measured serving — Most economical option for higher-dose protocols or stackers; requires a milligram-accurate scale; no excipients or additives; not recommended for beginners unfamiliar with powder dosing
As an Amazon Associate we earn from qualifying purchases. Shilajit quality varies widely — always choose a product with a published third-party heavy-metal test (COA) before buying.
A Note on the Evidence
The research on C15:0 is early-stage, largely originating from a single research group, and has not yet been replicated at the scale or independence required to draw firm clinical conclusions; no C15:0 supplement has been evaluated by the FDA for any disease, and this article is informational only — not a substitute for personalized medical advice from a qualified healthcare provider.
Frequently Asked Questions
What foods are highest in C15:0?
Full-fat dairy products — butter, whole milk, cream, and aged cheeses — are the most consistent dietary sources of C15:0. Fatty marine fish and some fermented foods also contain detectable amounts. The C15:0 content of dairy varies with the animal’s diet, tending to be higher in grass-fed versus grain-fed ruminants.
Is C15:0 the same as a standard saturated fat?
C15:0 is technically a saturated fat, but its odd-chain length sets it apart from the more studied even-chain saturated fats like palmitic acid (C16:0) or stearic acid (C18:0). The body metabolizes odd-chain and even-chain fats through somewhat different pathways, and their associations with health markers in epidemiological research have not always pointed in the same direction.
Has the FDA approved C15:0 for any health condition?
No. The FDA has not evaluated C15:0 supplements for the treatment, prevention, or cure of any disease or health condition. C15:0 products are sold as dietary supplements, not drugs, and are not subject to the same pre-market approval requirements as pharmaceuticals.
What does 'partial PPAR agonism' mean in plain language?
PPAR-α and PPAR-δ are proteins inside cells that act like molecular switches, turning on genes involved in fat metabolism and inflammation regulation. A ‘partial agonist’ activates these switches at a moderate level rather than fully. Researchers propose this partial activation profile may be biologically meaningful without the side effects associated with full pharmaceutical PPAR agonists, but this comparison has not been tested in head-to-head clinical trials.
Can I get enough C15:0 from eating dairy instead of taking a supplement?
Dairy fat does provide C15:0, and for people who consume full-fat dairy regularly, it is a natural source of this fatty acid. Whether the amounts obtained from typical dairy consumption equal the doses studied in supplementation research is not clearly established. Individuals who avoid dairy or follow low-fat diets will have lower dietary exposure to C15:0.
Are there any known risks or side effects from C15:0 supplementation?
Published human studies at doses of 100–300 mg/day have not reported serious adverse events. However, the studies conducted to date have been small and relatively short-term, so a comprehensive long-term safety profile does not yet exist. Anyone with chronic health conditions, those taking lipid-modifying medications, or those who are pregnant or breastfeeding should speak with a healthcare provider before supplementing.
These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure, or prevent any disease. Content is for informational purposes only and is not medical advice; consult a qualified healthcare provider before starting any supplement. As an Amazon Associate we earn from qualifying purchases.
